Myocardial homing and coronary endothelial function after autologous blood CD34+ progenitor cells intracoronary injection in the chronic phase of myocardial infarction

Journal of Cardiovascular Pharmacology

Volumn 53, Issue 6, 2009, Pages 480-485

  Dedobbeleer, Chantal ^a   Blocklet, Didier ^a   Toungouz, Michel ^a   Lambermont, Micheline ^a   Unger, Philippe ^a   Degaute, Jean Paul ^a   Goldman, Serge ^a   Berkenboom, Guy ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Cellular therapy; Endothelial function; Myocardial infarction; Stem cells

Indexed keywords

BRADYKININ; IODIXANOL;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BALLOON CATHETER; BLOOD; CD34 SELECTION; CELL FUNCTION; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG DOSE INCREASE; ECHOCARDIOGRAPHY; ENDOTHELIUM CELL; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE VOLUME; HUMAN; INTERMETHOD COMPARISON; INTRACORONARY INFUSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

ADULT; AGED; ANTIGENS, CD34; BLOOD CELLS; CHRONIC DISEASE; CORONARY VESSELS; ECHOCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FEASIBILITY STUDIES; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, AUTOLOGOUS;

EID: 68249107687     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181a7b572     Document Type: Article

References (31)

1. Caspi O, Huber I, Kehat I, et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol. 2007;50:1884-1893. (Pubitemid 350007960)
2. Menasché P, Alfieri O, Janssens S, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation. 2008; 117:1189-1200. (Pubitemid 351552018)
3. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001;7:430-436.
4. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701-705. (Pubitemid 32290358)
5. Silva GV, Litovsky S, Assad JA, et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation. 2005;111:150-156. (Pubitemid 40139725)
6. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and supportmyocardial regeneration. Cell. 2003;114:763-776. (Pubitemid 37186770)
7. Schächinger V, Erbs S, Elsässer A, et al. REPAIR-AMI Investigators. Improved clinical outcome after intracoronary administration of bonemarrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J. 2006;27:2775-2783.
8. Schächinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol. 2004; 44:1690-1699. (Pubitemid 39369805)
9. Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med. 2006;355:1199-1209. (Pubitemid 44427444)
10. Meyer GP, Wollert KC, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation. 2006;113: 1287-1294. (Pubitemid 43739450)
11. Janssens S, Dubois C, Bogaert J, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet. 2006;367: 113-121. (Pubitemid 43077127)
12. Fuchs S, Satler LF, Kornowski R, et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. J Am Coll Cardiol. 2003; 41:1721-1724. (Pubitemid 36584242)
13. Kuethe F, Richartz BM, Kasper C, et al. Autologous intracoronary mononuclear bone marrow cell transplantation in chronic ischemic cardiomyopathy in humans. Int J Cardiol. 2005;100:485-491. (Pubitemid 40503297)
14. Assmus B, Fischer-Rasokat U, Honold J, et al. TOPCARE-CHD Registry. Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry. Circ Res. 2007;100:1234-1241.
15. Strauer BE, Brehm M, Zeus T, et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. J Am Coll Cardiol. 2005;46:1651-1658. (Pubitemid 41531618)
16. Blocklet D, Toungouz M, Berkenboom G, et al. Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection. Stem Cells. 2006;24:333-336. (Pubitemid 44464802)
17. Assmus B, Schächinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation. 2002;106:3009-3017. (Pubitemid 35440281)
18. Assmus B, Honold J, Schächinger V, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med. 2006;355: 1222-1232. (Pubitemid 44427446)
19. Xu M, Uemura R, Dai Y, et al. In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. J Mol Cell Cardiol. 2007;42: 441-448.
20. Erbs S, Linke A, Adams V, et al. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res. 2005;97: 756-762. (Pubitemid 41447125)
21. Higashi Y, Kimura M, Hara K, et al. Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation. 2004;109:1215-1218. (Pubitemid 38372778)
22. Gardin JM, Adams DB, Douglas PS, et al. American Society of Echocardiography. Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report. J Am Soc Echocardiogr. 2002;15:275-290. (Pubitemid 44970067)
23. Berkenboom G, Preumont N, Pradier O, et al. Relation of coronary hypersensitivity to serotonin in cardiac transplant recipients to vessel wall morphology and effect of vitamin C. Am J Cardiol. 2006;97:561-566. (Pubitemid 43190051)
24. Schächinger V, Aicher A, Döbert N, et al. Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. Circulation. 2008;118:1425-1432.
25. Hofmann M, Wollert KC, Meyer GP, et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation. 2005;111: 2198-2202. (Pubitemid 40632435)
26. Kang HJ, Kim HS, Koo BK, et al. Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow-up results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion (MAGIC Cell) 1 trial. Am Heart J. 2007;153:237.e1-237.e8.
27. Berkenboom G, Crasset V, Unger P, et al. Absence of L-arginine effect on coronary hypersensitivity to serotonin in cardiac transplant recipients. Am J Cardiol. 1999;84:1182-1186. (Pubitemid 29507499)
28. Kim JW, Suh SY, Choi CU, et al. Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus paclitaxel-eluting stent. J Am Coll Cardiol Interv. 2008;1:65-71.
29. Bartunek J, Vanderheyden M, Vandekerckhove B, et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation. 2005;112(Suppl 9):I178-I183. (Pubitemid 41266671)
30. Mansour S, Vanderheyden M, De Bruyne B, et al. Intracoronary delivery of hematopoietic bone marrow stem cells and luminal loss of the infarctrelated artery in patients with recent myocardial infarction. J Am Coll Cardiol. 2006;47:1727-1730.
31. Assmus B, Walter DH, Lehmann R, et al. Intracoronary infusion of progenitor cells is not associated with aggravated restenosis development or atherosclerotic disease progression in patients with acute myocardial infarction. Eur Heart J. 2006;27:2989-2995. (Pubitemid 44950443)